Literature DB >> 29572587

Neonatal Abstinence Syndrome (NAS) in Southwestern Border States: Examining Trends, Population Correlates, and Implications for Policy.

Khaleel S Hussaini1, Luigi F Garcia Saavedra2.   

Abstract

Introduction Neonatal abstinence syndrome (NAS) is withdrawal syndrome in newborns following birth and is primarily caused by maternal drug use during pregnancy. This study examines trends, population correlates, and policy implications of NAS in two Southwest border states. Materials and Methods A cross-sectional analysis of Hospital Inpatient Discharge Data (HIDD) was utilized to examine the incidence of NAS in the Southwest border states of Arizona (AZ) and New Mexico (NM). All inpatient hospital births in AZ and NM from January 1, 2008 through December 31, 2013 with ICD9-CM codes for NAS (779.5), cocaine (760.72), or narcotics (760.75) were extracted. Results During 2008-2013 there were 1472 NAS cases in AZ and 888 in NM. The overall NAS rate during this period was 2.83 per 1000 births (95% CI 2.68-2.97) in AZ and 5.31 (95% CI 4.96-5.66) in NM. NAS rates increased 157% in AZ and 174% in NM. NAS newborns were more likely to have low birth weight, have respiratory distress, more likely to have feeding difficulties, and more likely to be on state Medicaid insurance. AZ border region (border with Mexico) had NAS rates significantly higher than the state rate (4.06 per 1000 births [95% CI 3.68-4.44] vs. 2.83 [95% CI 2.68-2.97], respectively). In NM, the border region rate (2.09 per 1000 births [95% CI 1.48-2.69]) was significantly lower than the state rate (5.31 [95% CI 4.96-5.66]). Conclusions Despite a dramatic increase in the incidence of NAS in the U.S. and, in particular, the Southwest border states of AZ and NM, there is still scant research on the overall incidence of NAS, its assessment in the southwest border, and associated long-term outcomes. The Healthy Border (HB) 2020 binational initiative of the U.S.-Mexico Border Health Commission is an initiative that addresses several public health priorities that not only include chronic and degenerative diseases, infectious diseases, injury prevention, maternal and child health but also mental health and addiction. The growing opioid epidemic and rise in NAS cases in the Southwest border, as partially shown in this study, provides another opportunity to track health illnesses and outcomes in the Southwest border, especially because there are targeted resources through High Intensity Drug Trafficking Areas (HIDTA) funding.

Entities:  

Keywords:  Border health; Disparity; LBW; Neonatal abstinence syndrome (NAS); Population health; Respiratory difficulties; Southwest border

Mesh:

Substances:

Year:  2018        PMID: 29572587     DOI: 10.1007/s10995-018-2517-y

Source DB:  PubMed          Journal:  Matern Child Health J        ISSN: 1092-7875


  14 in total

1.  Increasing pregnancy-related use of prescribed opioid analgesics.

Authors:  Richard A Epstein; William V Bobo; Peter R Martin; James A Morrow; Wei Wang; Rameela Chandrasekhar; William O Cooper
Journal:  Ann Epidemiol       Date:  2013-08       Impact factor: 3.797

2.  Drug use in the high intensity drug trafficking area of the US Southwest border.

Authors:  L D Harrison; N J Kennedy
Journal:  Addiction       Date:  1996-01       Impact factor: 6.526

3.  First trimester initiation of prenatal care in the US-Mexico border region.

Authors:  Jill A McDonald; Brittany Argotsinger; Octavio Mojarro; Roger Rochat; Anup Amatya
Journal:  Med Care       Date:  2015-08       Impact factor: 2.983

4.  Confidence intervals rather than P values: estimation rather than hypothesis testing.

Authors:  M J Gardner; D G Altman
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-15

Review 5.  Neonatal Abstinence Syndrome.

Authors:  Karen McQueen; Jodie Murphy-Oikonen
Journal:  N Engl J Med       Date:  2016-12-22       Impact factor: 91.245

6.  Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009.

Authors:  Stephen W Patrick; Robert E Schumacher; Brian D Benneyworth; Elizabeth E Krans; Jennifer M McAllister; Matthew M Davis
Journal:  JAMA       Date:  2012-04-30       Impact factor: 56.272

Review 7.  Neonatal abstinence syndrome.

Authors:  Lauren M Jansson; Martha Velez
Journal:  Curr Opin Pediatr       Date:  2012-04       Impact factor: 2.856

8.  Incidence of Neonatal Abstinence Syndrome - 28 States, 1999-2013.

Authors:  Jean Y Ko; Stephen W Patrick; Van T Tong; Roshni Patel; Jennifer N Lind; Wanda D Barfield
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-08-12       Impact factor: 17.586

9.  Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012.

Authors:  S W Patrick; M M Davis; C U Lehmann; C U Lehman; W O Cooper
Journal:  J Perinatol       Date:  2015-04-30       Impact factor: 2.521

10.  Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study.

Authors:  Rishi J Desai; Krista F Huybrechts; Sonia Hernandez-Diaz; Helen Mogun; Elisabetta Patorno; Karol Kaltenbach; Leslie S Kerzner; Brian T Bateman
Journal:  BMJ       Date:  2015-05-14
View more
  2 in total

1.  Characterization of neonatal opioid withdrawal syndrome in Arizona from 2010-2017.

Authors:  Emery R Eaves; Jarrett Barber; Ryann Whealy; Sara A Clancey; Rita Wright; Jill Hager Cocking; Joseph Spadafino; Crystal M Hepp
Journal:  PLoS One       Date:  2021-06-03       Impact factor: 3.752

2.  Disparities in neonatal abstinence syndrome and health insurance status: A statewide study using non-claims real-time surveillance data.

Authors:  Amna Umer; Christa Lilly; Candice Hamilton; Janine Breyel; Lindsay Allen; Ancilla Rompala; Carrie Moore; Patricia O'Dierno; Collin John
Journal:  Paediatr Perinat Epidemiol       Date:  2020-10-27       Impact factor: 3.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.